Grigorios Siokas Buys 353,321 Shares of Cosmos Health (NASDAQ:COSM) Stock

Posted by Latisha Jones on Jan 23rd, 2026

Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas acquired 353,321 shares of the firm’s stock in a transaction on Tuesday, January 20th. The stock was purchased at an average price of $0.50 per share, with a total value of $176,660.50. Following the acquisition, the chief executive officer owned 8,091,795 shares of the company’s stock, valued at $4,045,897.50. This represents a 4.57% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Grigorios Siokas also recently made the following trade(s):

On Wednesday, January 14th, Grigorios Siokas bought 493,495 shares of Cosmos Health stock. The shares were acquired at an average price of $0.45 per share, for a total transaction of $222,072.75.
On Monday, January 12th, Grigorios Siokas bought 113,185 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.50 per share, for a total transaction of $56,592.50.
On Thursday, January 8th, Grigorios Siokas purchased 156,190 shares of Cosmos Health stock. The stock was acquired at an average price of $0.52 per share, with a total value of $81,218.80.
On Wednesday, January 7th, Grigorios Siokas purchased 124,880 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.52 per share, with a total value of $64,937.60.
On Tuesday, January 6th, Grigorios Siokas acquired 133,953 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.54 per share, for a total transaction of $72,334.62.
On Friday, December 19th, Grigorios Siokas acquired 88,314 shares of Cosmos Health stock. The stock was acquired at an average price of $0.49 per share, for a total transaction of $43,273.86.
On Monday, December 15th, Grigorios Siokas bought 168,472 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.42 per share, with a total value of $70,758.24.
On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The shares were acquired at an average price of $0.64 per share, with a total value of $48,870.40.
On Tuesday, November 25th, Grigorios Siokas purchased 55,732 shares of Cosmos Health stock. The stock was bought at an average cost of $0.63 per share, for a total transaction of $35,111.16.
On Friday, November 21st, Grigorios Siokas purchased 56,080 shares of Cosmos Health stock. The stock was bought at an average price of $0.68 per share, for a total transaction of $38,134.40.

Cosmos Health Stock Down 2.6%

Shares of NASDAQ:COSM opened at $0.51 on Friday. The stock has a fifty day simple moving average of $0.54 and a two-hundred day simple moving average of $0.73. The stock has a market capitalization of $18.95 million, a price-to-earnings ratio of -0.68 and a beta of 5.37. Cosmos Health Inc. has a 12-month low of $0.28 and a 12-month high of $1.32. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25.

Cosmos Health (NASDAQ:COSM – Get Free Report) last released its earnings results on Friday, November 14th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). The company had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. On average, research analysts anticipate that Cosmos Health Inc. will post -0.78 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Citadel Advisors LLC lifted its stake in Cosmos Health Inc. (NASDAQ:COSM – Free Report) by 133.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 225,507 shares of the company’s stock after acquiring an additional 128,776 shares during the quarter. Citadel Advisors LLC owned 0.65% of Cosmos Health worth $250,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 12.61% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Check Out Our Latest Stock Analysis on Cosmos Health

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.